Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1931 1
1950 1
1959 1
1961 1
1962 2
1964 1
1965 2
1968 3
1969 2
1970 2
1971 1
1972 1
1973 3
1974 1
1975 2
1977 1
1978 1
1979 2
1980 1
1981 2
1982 4
1983 2
1984 6
1985 5
1986 2
1987 4
1988 3
1989 4
1990 4
1991 4
1992 3
1993 2
1994 15
1995 2
1996 9
1997 9
1998 16
1999 12
2000 21
2001 17
2002 20
2003 12
2004 18
2005 20
2006 36
2007 39
2008 36
2009 57
2010 47
2011 73
2012 68
2013 71
2014 77
2015 81
2016 89
2017 102
2018 111
2019 118
2020 151
2021 205
2022 191
2023 171
2024 210
2025 247
2026 69

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,216 results

Results by year

Filters applied: . Clear all
Page 1
The p-MYH9/USP22/HIF-1α axis promotes lenvatinib resistance and cancer stemness in hepatocellular carcinoma.
Shan Q, Yin L, Zhan Q, Yu J, Pan S, Zhuo J, Zhou W, Bao J, Zhang L, Hong J, Xiang J, Que Q, Chen K, Xu S, Wang J, Zhu Y, He B, Wu J, Xie H, Zheng S, Feng T, Ling S, Xu X. Shan Q, et al. Among authors: ling s. Signal Transduct Target Ther. 2024 Sep 19;9(1):249. doi: 10.1038/s41392-024-01963-5. Signal Transduct Target Ther. 2024. PMID: 39300073 Free PMC article.
Dendritic-cell-targeting virus-like particles as potent mRNA vaccine carriers.
Yin D, Zhong Y, Ling S, Lu S, Wang X, Jiang Z, Wang J, Dai Y, Tian X, Huang Q, Wang X, Chen J, Li Z, Li Y, Xu Z, Jiang H, Wu Y, Shi Y, Wang Q, Xu J, Hong W, Xue H, Yang H, Zhang Y, Da L, Han ZG, Tao SC, Dong R, Ying T, Hong J, Cai Y. Yin D, et al. Among authors: ling s. Nat Biomed Eng. 2025 Feb;9(2):185-200. doi: 10.1038/s41551-024-01208-4. Epub 2024 May 7. Nat Biomed Eng. 2025. PMID: 38714892
In vivo CRISPR gene editing in patients with herpetic stromal keratitis.
Wei A, Yin D, Zhai Z, Ling S, Le H, Tian L, Xu J, Paludan SR, Cai Y, Hong J. Wei A, et al. Among authors: ling s. Mol Ther. 2023 Nov 1;31(11):3163-3175. doi: 10.1016/j.ymthe.2023.08.021. Epub 2023 Aug 31. Mol Ther. 2023. PMID: 37658603 Free PMC article. Clinical Trial.
Customizable virus-like particles deliver CRISPR-Cas9 ribonucleoprotein for effective ocular neovascular and Huntington's disease gene therapy.
Ling S, Zhang X, Dai Y, Jiang Z, Zhou X, Lu S, Qian X, Liu J, Selfjord N, Satir TM, Lundin A, Touza JL, Firth M, Van Zuydam N, Bilican B, Akcakaya P, Hong J, Cai Y. Ling S, et al. Nat Nanotechnol. 2025 Apr;20(4):543-553. doi: 10.1038/s41565-024-01851-7. Epub 2025 Feb 10. Nat Nanotechnol. 2025. PMID: 39930103 Free PMC article.
Isatuximab Subcutaneous by On-Body Injector Versus Isatuximab Intravenous Plus Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Phase III IRAKLIA Study.
Ailawadhi S, Špička I, Spencer A, Lu J, Oriol A, Ling S, Schjesvold F, Berkovits A, Hus M, Li C, Dimopoulos MA, Rajnics P, Beşışık SK, Hungria V, Custidiano MDR, Parmar G, Leleu X, Li F, Cerchione C, Gomez C, Ishida T, Mateos MV, Buck TT, LeBlanc R, Minařík J, Goldschmidt H, Zhang R, Sémiond D, Suzan F, Stefanova-Urena M, Koch V, Moreau P. Ailawadhi S, et al. Among authors: ling s. J Clin Oncol. 2025 Aug;43(22):2527-2537. doi: 10.1200/JCO-25-00744. Epub 2025 Jun 3. J Clin Oncol. 2025. PMID: 40459178 Clinical Trial.
Modified lentiviral globin gene therapy for pediatric β0/β0 transfusion-dependent β-thalassemia: A single-center, single-arm pilot trial.
Li S, Ling S, Wang D, Wang X, Hao F, Yin L, Yuan Z, Liu L, Zhang L, Li Y, Chen Y, Luo L, Dai Y, Zhang L, Chen L, Deng D, Tang W, Zhang S, Wang S, Cai Y. Li S, et al. Among authors: ling s. Cell Stem Cell. 2024 Jul 5;31(7):961-973.e8. doi: 10.1016/j.stem.2024.04.021. Epub 2024 May 16. Cell Stem Cell. 2024. PMID: 38759653 Free article. Clinical Trial.
Clinical impact of pharmacogenetic risk variants in a large chinese cohort.
Wei CY, Wen MS, Cheng CK, Sheen YJ, Yao TC, Lee SL, Wu JY, Tsai MF, Li LH, Chen CH, Fann CS, Yang HC, Huang YT, Chen HH, Liu YM, Yeh EC, Peng YC, Wang SJ, Chen SP, Tsai MT, Huo TI, Su CW, Tarng DC, Huang CC, Fuh JL, Lan KH, Liu YT, Lu CL, Lee YC, Huang YH, Li CP, Wang YF, Hsieh YC, Chen YM, Hsiao TH, Lin CH, Chen YJ, Chen IC, Mao CL, Chang SJ, Chang YL, Liao YJ, Lai CH, Lee WJ, Tung H, Yen TT, Yen HC, Chang JH, Huang CY, Chan L, Lin YW, Hsiao BY, Hu CJ, Lin YK, Lin YF, Chang TC, Wu DC, Kan JY, Hsu CY, Chen SC, Li CC, Huang CF, Sheu CC, Yang LJ, Chen CH, Chen KM, Chang SM, Liou MS, Wang SP, Lin KT, Chuang HP, Chen YJ, Sin J, Chen YT, Chang CC, Kuo CF, Lin JC, Kuo HC, Chan TM, Lee CW, Lai JH, Luo SF, Cheng HT, Lin LY, Chang LC, Tsai CT, Kao HL, Yu JJ, Jeng JS, Chiu MC, Hong TC, Yang SF, Lu HJ, Su SC, Chu P, Li PF, Tsai CL, Tsai CK, Tang SE, Lin CM, Wu YF, Huang CY, Ling SZ, Chang CC, Lin TK, Hsiao SM, Chang CH, Chen CD, Ma GC, Chang TY, Hwang JJ, Lu CL, Kao KJ, Hung CF, Chen SS, Chen PY, Tsui K, Chen YT, Chen CH, Chien CC, Chiang HS, Chiu YL, Chen HC, Kwok PY. Wei CY, et al. Among authors: ling sz. Nat Commun. 2025 Jul 9;16(1):6344. doi: 10.1038/s41467-025-61644-x. Nat Commun. 2025. PMID: 40634300 Free PMC article.
2,216 results